Vivos (RDGL) Cash & Equivalents (2010 - 2025)

Vivos has disclosed Cash & Equivalents across 16 years of filings, most recently posting $1.6 million for Q4 2025.

• Cash & Equivalents for Q4 2025 came in at $1.6 million, down 29.56% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.6 million (down 29.56% YoY), and the FY2025 annual result was $1.6 million, down 29.56% from the prior year.
• Cash & Equivalents came in at $1.6 million for Q4 2025 at Vivos, down from $2.2 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $3.3 million in Q1 2025 to a low of $1.1 million in Q2 2022.
• The 5-year median for Cash & Equivalents is $1.7 million (2022), against an average of $1.8 million.
• Across the five-year window, Cash & Equivalents surged 13202.47% in 2021 and slumped 51.46% in 2022, its largest moves.
• Vivos' Cash & Equivalents stood at $1.6 million in 2021, then grew by 6.22% to $1.7 million in 2022, then decreased by 6.67% to $1.6 million in 2023, then surged by 38.95% to $2.2 million in 2024, then decreased by 29.56% to $1.6 million in 2025.
• The last three Cash & Equivalents figures came in at $1.6 million (Q4 2025), $2.2 million (Q3 2025), and $2.7 million (Q2 2025), per Business Quant data.